Strain-Specific Differences in the Genetic Control of Two Closely Related Mycobacteria
暂无分享,去创建一个
Marcel A. Behr | J. Concepción Loredo-Osti | M. Behr | J. Loredo-Osti | C. Hernández | E. Schurr | M. Girard | Tania Di Pietrantonio | Carmen Hernandez | Manon Girard | Annie Verville | Marianna Orlova | Adam Belley | Erwin Schurr | M. Orlova | A. Verville | Tania Di Pietrantonio | A. Belley | T. D. Pietrantonio | Erwin Schurr | Marcel A. Behr
[1] P. Gros,et al. Pyruvate kinase deficiency in mice protects against malaria , 2003, Nature Genetics.
[2] Tim W. Overton,et al. Point mutations in the DNA- and cNMP-binding domains of the homologue of the cAMP receptor protein (CRP) in Mycobacterium bovis BCG: implications for the inactivation of a global regulator and strain attenuation. , 2005, Microbiology.
[3] T. Gingeras,et al. Detection of deleted genomic DNA using a semiautomated computational analysis of GeneChip data. , 2000, Genome research.
[4] L. Laroche,et al. Recombinant congenic strains derived from A/J and C57BL/6J: a tool for genetic dissection of complex traits. , 2001, Genomics.
[5] Priscille Brodin,et al. Loss of RD1 contributed to the attenuation of the live tuberculosis vaccines Mycobacterium bovis BCG and Mycobacterium microti , 2002, Molecular microbiology.
[6] C. Dye,et al. Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness , 2006, The Lancet.
[7] M. Behr,et al. The in vitro evolution of BCG vaccines. , 2003, Vaccine.
[8] M. Behr,et al. A historical and molecular phylogeny of BCG strains. , 1999, Vaccine.
[9] J. Blackwell,et al. BCG-induced increase in interferon-gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies , 2002, The Lancet.
[10] E. Schurr. Is susceptibility to tuberculosis acquired or inherited? , 2007, Journal of internal medicine.
[11] Stefan Niemann,et al. Variable host-pathogen compatibility in Mycobacterium tuberculosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.
[12] M. Behr,et al. TB: Screening for Responses to a Vile Visitor , 2010, Cell.
[13] O. Werz,et al. ALOX5 variants associated with susceptibility to human pulmonary tuberculosis. , 2007, Human molecular genetics.
[14] A. Hart,et al. Recombinant congenic strains — A new tool for analyzing genetic traits determined by more than one gene , 2004, Immunogenetics.
[15] P. Hozák,et al. Use of recombinant congenic strains in mapping disease-modifying genes. , 2004, News in physiological sciences : an international journal of physiology produced jointly by the International Union of Physiological Sciences and the American Physiological Society.
[16] Julian Parkhill,et al. Genome plasticity of BCG and impact on vaccine efficacy , 2007, Proceedings of the National Academy of Sciences.
[17] D. Malo,et al. Natural resistance to infection with intracellular parasites: Isolation of a candidate for Bcg , 1993, Cell.
[18] J. Mckinney,et al. Role of KatG catalase‐peroxidase in mycobacterial pathogenesis: countering the phagocyte oxidative burst , 2004, Molecular microbiology.
[19] C. Nathan,et al. The Proteasome of Mycobacterium tuberculosis Is Required for Resistance to Nitric Oxide , 2003, Science.
[20] M. Behr,et al. Reduced expression of antigenic proteins MPB70 and MPB83 in Mycobacterium bovis BCG strains due to a start codon mutation in sigK , 2005, Molecular microbiology.
[21] S. Kaufmann,et al. Handbook of Tuberculosis , 2008 .
[22] B. Taylor,et al. Host response to infection with mycobacterium bovis (BCG) in mice: genetic study of natural resistance. , 1983, Advances in experimental medicine and biology.
[23] Minjian Chen,et al. Lipid mediators in innate immunity against tuberculosis: opposing roles of PGE2 and LXA4 in the induction of macrophage death , 2008, The Journal of experimental medicine.
[24] W. Altemeier,et al. Natural Resistance to Infection. , 1961, Progress in surgery.
[25] S. Fortune,et al. Mycobacterium tuberculosis evades macrophage defenses by inhibiting plasma membrane repair , 2009, Nature Immunology.
[26] P. Small,et al. Unique Gene Expression Profiles in Infants Vaccinated with Different Strains of Mycobacterium bovis Bacille Calmette-Guérin , 2007, Infection and Immunity.
[27] Sebastien Gagneux,et al. Global phylogeography of Mycobacterium tuberculosis and implications for tuberculosis product development. , 2007, The Lancet. Infectious diseases.
[28] M. Behr,et al. A Point Mutation in the mma3 Gene Is Responsible for Impaired Methoxymycolic Acid Production in Mycobacterium bovis BCG Strains Obtained after 1927 , 2000, Journal of bacteriology.
[29] R. Sladek,et al. Identification of novel chromosomal regions associated with airway hyperresponsiveness in recombinant congenic strains of mice , 2010, Mammalian Genome.
[30] P. Gros,et al. Genetic control of natural resistance to Mycobacterium bovis (BCG) in mice. , 1981, Journal of immunology.
[31] R. Wilkinson,et al. The clinical consequences of strain diversity in Mycobacterium tuberculosis. , 2008, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[32] D. Sherman,et al. Deletion of RD1 from Mycobacterium tuberculosis mimics bacille Calmette-Guérin attenuation. , 2003, The Journal of infectious diseases.
[33] C. Greenwood,et al. Linkage of tuberculosis to chromosome 2q35 loci, including NRAMP1, in a large aboriginal Canadian family. , 2000, American journal of human genetics.
[34] M. Newport,et al. Population differences in immune responses to Bacille Calmette-Guérin vaccination in infancy. , 2009, The Journal of infectious diseases.
[35] B. Zhu,et al. BCG Vaccines: Their mechanisms of attenuation and impact on safety and protective efficacy , 2009, Human vaccines.
[36] David M. Tobin,et al. The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans , 2010, Cell.
[37] G. Mahairas,et al. Molecular analysis of genetic differences between Mycobacterium bovis BCG and virulent M. bovis , 1996, Journal of bacteriology.
[38] K. Hasløv,et al. Development of the Mycobacterium bovis BCG vaccine: review of the historical and biochemical evidence for a genealogical tree. , 1999, Tubercle and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[39] D. Malo,et al. Pyruvate kinase deficiency confers susceptibility to Salmonella typhimurium infection in mice , 2007, The Journal of experimental medicine.
[40] D. Sherman,et al. Impact of Methoxymycolic Acid Production by Mycobacterium bovis BCG Vaccines , 2004, Infection and Immunity.
[41] J. Farrar,et al. The Influence of Host and Bacterial Genotype on the Development of Disseminated Disease with Mycobacterium tuberculosis , 2008, PLoS pathogens.
[42] M. Reed,et al. Major Mycobacterium tuberculosis Lineages Associate with Patient Country of Origin , 2009, Journal of Clinical Microbiology.
[43] S. Niemann,et al. Autophagy Gene Variant IRGM −261T Contributes to Protection from Tuberculosis Caused by Mycobacterium tuberculosis but Not by M. africanum Strains , 2009, PLoS pathogens.
[44] E. Böttger,et al. Tuberculosis vaccine strain Mycobacterium bovis BCG Russia is a natural recA mutant , 2008, BMC Microbiology.